A structural mechanism for directing corepressor-selective inverse agonism of PPARγ
Peroxisome proliferator-activated receptor gamma (PPARγ) is a target for insulin sensitizing drugs. Here the authors combine NMR, X-ray crystallography and MD simulations and report a structural mechanism for eliciting PPARγ inverse agonism, where coactivator binding is inhibited and corepressor bin...
Guardado en:
Autores principales: | Richard Brust, Jinsai Shang, Jakob Fuhrmann, Sarah A. Mosure, Jared Bass, Andrew Cano, Zahra Heidari, Ian M. Chrisman, Michelle D. Nemetchek, Anne-Laure Blayo, Patrick R. Griffin, Theodore M. Kamenecka, Travis S. Hughes, Douglas J. Kojetin |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Nature Portfolio
2018
|
Materias: | |
Acceso en línea: | https://doaj.org/article/83045b413545471dafc949ec4db32b64 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Defining a conformational ensemble that directs activation of PPARγ
por: Ian M. Chrisman, et al.
Publicado: (2018) -
Definition of functionally and structurally distinct repressive states in the nuclear receptor PPARγ
por: Zahra Heidari, et al.
Publicado: (2019) -
A molecular switch regulating transcriptional repression and activation of PPARγ
por: Jinsai Shang, et al.
Publicado: (2020) -
Oxaliplatin neurotoxicity involves peroxisome alterations. PPARγ agonism as preventive pharmacological approach.
por: Matteo Zanardelli, et al.
Publicado: (2014) -
Scaffold-based pan-agonist design for the PPARα, PPARβ and PPARγ receptors.
por: Li-Song Zhang, et al.
Publicado: (2012)